C&Y Pharmaceutical: The impact of U.S. tariff policies on the company is relatively small

On April 9th, C&Y Pharmaceutical stated on the interactive platform that a small amount of auxiliary materials is sourced from the United States, accounting for less than 0.3% of the company's total procurement; at the same time, the company has a small amount of health food exports to Southeast Asia, accounting for less than 0.03% of the company's operating revenue; the impact of U.S. tariff policies on the company is relatively small